世界の革新的医療市場の成長(現状と展望)2024-2030年Global Innovative Medicine Market Growth (Status and Outlook) 2024-2030 LPI(LPインフォメーション)の最新調査によると、世界の革新的医薬品の市場規模は2023年に100万米ドルと評価されました。川下市場の需要拡大に伴い、革新的医薬品はレビュー期間中の年平均成長率(CAGR)%で203... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(LPインフォメーション)の最新調査によると、世界の革新的医薬品の市場規模は2023年に100万米ドルと評価されました。川下市場の需要拡大に伴い、革新的医薬品はレビュー期間中の年平均成長率(CAGR)%で2030年までに百万米ドルの再調整規模になると予測されています。この調査レポートは、世界の革新的医薬品市場の成長可能性を明らかにしています。革新的医薬品は、今後の市場において安定した成長を示すと予想される。しかし、製品の差別化、コストの削減、サプライチェーンの最適化は、革新的医薬品の普及に不可欠であることに変わりはありません。市場関係者は、革新的医薬品市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。 世界の医薬品市場は、2022年には1,475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的医薬品が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。 主な特徴 革新的医薬品市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、革新的医薬品市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(生物学的医学、化学的医学など)、地域別内訳などが含まれます。 市場促進要因と課題:政府規制、環境問題、技術進歩、消費者嗜好の変化など、革新的医薬品市場の成長を促進する要因を特定・分析することができる。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。 競合情勢:この調査レポートは、革新的医療市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発:この調査レポートは、革新的医薬品業界における最新の技術開発について掘り下げることができます。これには、革新的医学技術の進歩、革新的医学の新規参入、革新的医学の新規投資、革新的医学の将来を形作るその他の技術革新が含まれます。 川下の事業者の好み:本レポートは、革新的医療市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買決定、革新的医療製品に対する嗜好に影響を与える要因が含まれています。 政府の政策とインセンティブ:調査レポートは、政府の政策やインセンティブが革新的医療市場に与える影響を分析する。これには、規制の枠組み、補助金、税制優遇措置、革新医療市場の促進を目的としたその他の措置の評価が含まれる。また、市場成長促進におけるこれらの政策の効果も評価する。 環境への影響と持続可能性当調査レポートでは、革新的医薬品市場の環境への影響と持続可能性の側面を評価する。 市場予測と将来展望:調査レポートは、実施した分析に基づいて、革新的医薬品産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれる。 提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられている。市場関係者が新たなトレンドを活用し、課題を克服し、革新的医薬品市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 革新医療市場はタイプ別と用途別に分類される。2019-2030年の期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。 タイプ別セグメント 生物医学 化学医薬品 用途別セグメント 腫瘍学 神経科学 免疫学 呼吸器 その他 本レポートはまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ファイザー ロシュ サノフィ ジョンソン・エンド・ジョンソン メルク・アンド・カンパニー ノバルティス アッヴィ ギリアド・サイエンシズ グラクソ・スミスクライン アムジェン アストラゼネカ ブリストル・マイヤーズ スクイブ イーライリリー バイエル ノボ ノルディスク アラガン 武田薬品 ベーリンガーインゲルハイム 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Innovative Medicine Market Size 2019-2030 2.1.2 Innovative Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Innovative Medicine Segment by Type 2.2.1 Biological Medicine 2.2.2 Chemical Medicine 2.3 Innovative Medicine Market Size by Type 2.3.1 Innovative Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Innovative Medicine Market Size Market Share by Type (2019-2024) 2.4 Innovative Medicine Segment by Application 2.4.1 Oncology 2.4.2 Neurosciences 2.4.3 Immunology 2.4.4 Respiratory 2.4.5 Others 2.5 Innovative Medicine Market Size by Application 2.5.1 Innovative Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Innovative Medicine Market Size Market Share by Application (2019-2024) 3 Innovative Medicine Market Size by Player 3.1 Innovative Medicine Market Size Market Share by Players 3.1.1 Global Innovative Medicine Revenue by Players (2019-2024) 3.1.2 Global Innovative Medicine Revenue Market Share by Players (2019-2024) 3.2 Global Innovative Medicine Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Innovative Medicine by Regions 4.1 Innovative Medicine Market Size by Regions (2019-2024) 4.2 Americas Innovative Medicine Market Size Growth (2019-2024) 4.3 APAC Innovative Medicine Market Size Growth (2019-2024) 4.4 Europe Innovative Medicine Market Size Growth (2019-2024) 4.5 Middle East & Africa Innovative Medicine Market Size Growth (2019-2024) 5 Americas 5.1 Americas Innovative Medicine Market Size by Country (2019-2024) 5.2 Americas Innovative Medicine Market Size by Type (2019-2024) 5.3 Americas Innovative Medicine Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Innovative Medicine Market Size by Region (2019-2024) 6.2 APAC Innovative Medicine Market Size by Type (2019-2024) 6.3 APAC Innovative Medicine Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Innovative Medicine by Country (2019-2024) 7.2 Europe Innovative Medicine Market Size by Type (2019-2024) 7.3 Europe Innovative Medicine Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Innovative Medicine by Region (2019-2024) 8.2 Middle East & Africa Innovative Medicine Market Size by Type (2019-2024) 8.3 Middle East & Africa Innovative Medicine Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Innovative Medicine Market Forecast 10.1 Global Innovative Medicine Forecast by Regions (2025-2030) 10.1.1 Global Innovative Medicine Forecast by Regions (2025-2030) 10.1.2 Americas Innovative Medicine Forecast 10.1.3 APAC Innovative Medicine Forecast 10.1.4 Europe Innovative Medicine Forecast 10.1.5 Middle East & Africa Innovative Medicine Forecast 10.2 Americas Innovative Medicine Forecast by Country (2025-2030) 10.2.1 United States Innovative Medicine Market Forecast 10.2.2 Canada Innovative Medicine Market Forecast 10.2.3 Mexico Innovative Medicine Market Forecast 10.2.4 Brazil Innovative Medicine Market Forecast 10.3 APAC Innovative Medicine Forecast by Region (2025-2030) 10.3.1 China Innovative Medicine Market Forecast 10.3.2 Japan Innovative Medicine Market Forecast 10.3.3 Korea Innovative Medicine Market Forecast 10.3.4 Southeast Asia Innovative Medicine Market Forecast 10.3.5 India Innovative Medicine Market Forecast 10.3.6 Australia Innovative Medicine Market Forecast 10.4 Europe Innovative Medicine Forecast by Country (2025-2030) 10.4.1 Germany Innovative Medicine Market Forecast 10.4.2 France Innovative Medicine Market Forecast 10.4.3 UK Innovative Medicine Market Forecast 10.4.4 Italy Innovative Medicine Market Forecast 10.4.5 Russia Innovative Medicine Market Forecast 10.5 Middle East & Africa Innovative Medicine Forecast by Region (2025-2030) 10.5.1 Egypt Innovative Medicine Market Forecast 10.5.2 South Africa Innovative Medicine Market Forecast 10.5.3 Israel Innovative Medicine Market Forecast 10.5.4 Turkey Innovative Medicine Market Forecast 10.5.5 GCC Countries Innovative Medicine Market Forecast 10.6 Global Innovative Medicine Forecast by Type (2025-2030) 10.7 Global Innovative Medicine Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Innovative Medicine Product Offered 11.1.3 Pfizer Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Roche 11.2.1 Roche Company Information 11.2.2 Roche Innovative Medicine Product Offered 11.2.3 Roche Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Roche Main Business Overview 11.2.5 Roche Latest Developments 11.3 Sanofi 11.3.1 Sanofi Company Information 11.3.2 Sanofi Innovative Medicine Product Offered 11.3.3 Sanofi Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Sanofi Main Business Overview 11.3.5 Sanofi Latest Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Information 11.4.2 Johnson & Johnson Innovative Medicine Product Offered 11.4.3 Johnson & Johnson Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Johnson & Johnson Main Business Overview 11.4.5 Johnson & Johnson Latest Developments 11.5 Merck & Co. 11.5.1 Merck & Co. Company Information 11.5.2 Merck & Co. Innovative Medicine Product Offered 11.5.3 Merck & Co. Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Merck & Co. Main Business Overview 11.5.5 Merck & Co. Latest Developments 11.6 Novartis 11.6.1 Novartis Company Information 11.6.2 Novartis Innovative Medicine Product Offered 11.6.3 Novartis Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Novartis Main Business Overview 11.6.5 Novartis Latest Developments 11.7 AbbVie 11.7.1 AbbVie Company Information 11.7.2 AbbVie Innovative Medicine Product Offered 11.7.3 AbbVie Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 AbbVie Main Business Overview 11.7.5 AbbVie Latest Developments 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Information 11.8.2 Gilead Sciences Innovative Medicine Product Offered 11.8.3 Gilead Sciences Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Gilead Sciences Main Business Overview 11.8.5 Gilead Sciences Latest Developments 11.9 GlaxoSmithKline 11.9.1 GlaxoSmithKline Company Information 11.9.2 GlaxoSmithKline Innovative Medicine Product Offered 11.9.3 GlaxoSmithKline Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 GlaxoSmithKline Main Business Overview 11.9.5 GlaxoSmithKline Latest Developments 11.10 Amgen 11.10.1 Amgen Company Information 11.10.2 Amgen Innovative Medicine Product Offered 11.10.3 Amgen Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Amgen Main Business Overview 11.10.5 Amgen Latest Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Company Information 11.11.2 AstraZeneca Innovative Medicine Product Offered 11.11.3 AstraZeneca Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 AstraZeneca Main Business Overview 11.11.5 AstraZeneca Latest Developments 11.12 Bristol-Myers Squibb 11.12.1 Bristol-Myers Squibb Company Information 11.12.2 Bristol-Myers Squibb Innovative Medicine Product Offered 11.12.3 Bristol-Myers Squibb Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Bristol-Myers Squibb Main Business Overview 11.12.5 Bristol-Myers Squibb Latest Developments 11.13 Eli Lilly 11.13.1 Eli Lilly Company Information 11.13.2 Eli Lilly Innovative Medicine Product Offered 11.13.3 Eli Lilly Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Eli Lilly Main Business Overview 11.13.5 Eli Lilly Latest Developments 11.14 Bayer 11.14.1 Bayer Company Information 11.14.2 Bayer Innovative Medicine Product Offered 11.14.3 Bayer Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Bayer Main Business Overview 11.14.5 Bayer Latest Developments 11.15 Novo Nordisk 11.15.1 Novo Nordisk Company Information 11.15.2 Novo Nordisk Innovative Medicine Product Offered 11.15.3 Novo Nordisk Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 Novo Nordisk Main Business Overview 11.15.5 Novo Nordisk Latest Developments 11.16 Allergan 11.16.1 Allergan Company Information 11.16.2 Allergan Innovative Medicine Product Offered 11.16.3 Allergan Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 Allergan Main Business Overview 11.16.5 Allergan Latest Developments 11.17 Takeda 11.17.1 Takeda Company Information 11.17.2 Takeda Innovative Medicine Product Offered 11.17.3 Takeda Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Takeda Main Business Overview 11.17.5 Takeda Latest Developments 11.18 Boehringer Ingelheim 11.18.1 Boehringer Ingelheim Company Information 11.18.2 Boehringer Ingelheim Innovative Medicine Product Offered 11.18.3 Boehringer Ingelheim Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 Boehringer Ingelheim Main Business Overview 11.18.5 Boehringer Ingelheim Latest Developments 12 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Innovative Medicine market size was valued at US$ million in 2023. With growing demand in downstream market, the Innovative Medicine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Innovative Medicine Market Size 2019-2030 2.1.2 Innovative Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Innovative Medicine Segment by Type 2.2.1 Biological Medicine 2.2.2 Chemical Medicine 2.3 Innovative Medicine Market Size by Type 2.3.1 Innovative Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Innovative Medicine Market Size Market Share by Type (2019-2024) 2.4 Innovative Medicine Segment by Application 2.4.1 Oncology 2.4.2 Neurosciences 2.4.3 Immunology 2.4.4 Respiratory 2.4.5 Others 2.5 Innovative Medicine Market Size by Application 2.5.1 Innovative Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Innovative Medicine Market Size Market Share by Application (2019-2024) 3 Innovative Medicine Market Size by Player 3.1 Innovative Medicine Market Size Market Share by Players 3.1.1 Global Innovative Medicine Revenue by Players (2019-2024) 3.1.2 Global Innovative Medicine Revenue Market Share by Players (2019-2024) 3.2 Global Innovative Medicine Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Innovative Medicine by Regions 4.1 Innovative Medicine Market Size by Regions (2019-2024) 4.2 Americas Innovative Medicine Market Size Growth (2019-2024) 4.3 APAC Innovative Medicine Market Size Growth (2019-2024) 4.4 Europe Innovative Medicine Market Size Growth (2019-2024) 4.5 Middle East & Africa Innovative Medicine Market Size Growth (2019-2024) 5 Americas 5.1 Americas Innovative Medicine Market Size by Country (2019-2024) 5.2 Americas Innovative Medicine Market Size by Type (2019-2024) 5.3 Americas Innovative Medicine Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Innovative Medicine Market Size by Region (2019-2024) 6.2 APAC Innovative Medicine Market Size by Type (2019-2024) 6.3 APAC Innovative Medicine Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Innovative Medicine by Country (2019-2024) 7.2 Europe Innovative Medicine Market Size by Type (2019-2024) 7.3 Europe Innovative Medicine Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Innovative Medicine by Region (2019-2024) 8.2 Middle East & Africa Innovative Medicine Market Size by Type (2019-2024) 8.3 Middle East & Africa Innovative Medicine Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Innovative Medicine Market Forecast 10.1 Global Innovative Medicine Forecast by Regions (2025-2030) 10.1.1 Global Innovative Medicine Forecast by Regions (2025-2030) 10.1.2 Americas Innovative Medicine Forecast 10.1.3 APAC Innovative Medicine Forecast 10.1.4 Europe Innovative Medicine Forecast 10.1.5 Middle East & Africa Innovative Medicine Forecast 10.2 Americas Innovative Medicine Forecast by Country (2025-2030) 10.2.1 United States Innovative Medicine Market Forecast 10.2.2 Canada Innovative Medicine Market Forecast 10.2.3 Mexico Innovative Medicine Market Forecast 10.2.4 Brazil Innovative Medicine Market Forecast 10.3 APAC Innovative Medicine Forecast by Region (2025-2030) 10.3.1 China Innovative Medicine Market Forecast 10.3.2 Japan Innovative Medicine Market Forecast 10.3.3 Korea Innovative Medicine Market Forecast 10.3.4 Southeast Asia Innovative Medicine Market Forecast 10.3.5 India Innovative Medicine Market Forecast 10.3.6 Australia Innovative Medicine Market Forecast 10.4 Europe Innovative Medicine Forecast by Country (2025-2030) 10.4.1 Germany Innovative Medicine Market Forecast 10.4.2 France Innovative Medicine Market Forecast 10.4.3 UK Innovative Medicine Market Forecast 10.4.4 Italy Innovative Medicine Market Forecast 10.4.5 Russia Innovative Medicine Market Forecast 10.5 Middle East & Africa Innovative Medicine Forecast by Region (2025-2030) 10.5.1 Egypt Innovative Medicine Market Forecast 10.5.2 South Africa Innovative Medicine Market Forecast 10.5.3 Israel Innovative Medicine Market Forecast 10.5.4 Turkey Innovative Medicine Market Forecast 10.5.5 GCC Countries Innovative Medicine Market Forecast 10.6 Global Innovative Medicine Forecast by Type (2025-2030) 10.7 Global Innovative Medicine Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Innovative Medicine Product Offered 11.1.3 Pfizer Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Roche 11.2.1 Roche Company Information 11.2.2 Roche Innovative Medicine Product Offered 11.2.3 Roche Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Roche Main Business Overview 11.2.5 Roche Latest Developments 11.3 Sanofi 11.3.1 Sanofi Company Information 11.3.2 Sanofi Innovative Medicine Product Offered 11.3.3 Sanofi Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Sanofi Main Business Overview 11.3.5 Sanofi Latest Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Information 11.4.2 Johnson & Johnson Innovative Medicine Product Offered 11.4.3 Johnson & Johnson Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Johnson & Johnson Main Business Overview 11.4.5 Johnson & Johnson Latest Developments 11.5 Merck & Co. 11.5.1 Merck & Co. Company Information 11.5.2 Merck & Co. Innovative Medicine Product Offered 11.5.3 Merck & Co. Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Merck & Co. Main Business Overview 11.5.5 Merck & Co. Latest Developments 11.6 Novartis 11.6.1 Novartis Company Information 11.6.2 Novartis Innovative Medicine Product Offered 11.6.3 Novartis Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Novartis Main Business Overview 11.6.5 Novartis Latest Developments 11.7 AbbVie 11.7.1 AbbVie Company Information 11.7.2 AbbVie Innovative Medicine Product Offered 11.7.3 AbbVie Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 AbbVie Main Business Overview 11.7.5 AbbVie Latest Developments 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Information 11.8.2 Gilead Sciences Innovative Medicine Product Offered 11.8.3 Gilead Sciences Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Gilead Sciences Main Business Overview 11.8.5 Gilead Sciences Latest Developments 11.9 GlaxoSmithKline 11.9.1 GlaxoSmithKline Company Information 11.9.2 GlaxoSmithKline Innovative Medicine Product Offered 11.9.3 GlaxoSmithKline Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 GlaxoSmithKline Main Business Overview 11.9.5 GlaxoSmithKline Latest Developments 11.10 Amgen 11.10.1 Amgen Company Information 11.10.2 Amgen Innovative Medicine Product Offered 11.10.3 Amgen Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Amgen Main Business Overview 11.10.5 Amgen Latest Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Company Information 11.11.2 AstraZeneca Innovative Medicine Product Offered 11.11.3 AstraZeneca Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 AstraZeneca Main Business Overview 11.11.5 AstraZeneca Latest Developments 11.12 Bristol-Myers Squibb 11.12.1 Bristol-Myers Squibb Company Information 11.12.2 Bristol-Myers Squibb Innovative Medicine Product Offered 11.12.3 Bristol-Myers Squibb Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 Bristol-Myers Squibb Main Business Overview 11.12.5 Bristol-Myers Squibb Latest Developments 11.13 Eli Lilly 11.13.1 Eli Lilly Company Information 11.13.2 Eli Lilly Innovative Medicine Product Offered 11.13.3 Eli Lilly Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Eli Lilly Main Business Overview 11.13.5 Eli Lilly Latest Developments 11.14 Bayer 11.14.1 Bayer Company Information 11.14.2 Bayer Innovative Medicine Product Offered 11.14.3 Bayer Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Bayer Main Business Overview 11.14.5 Bayer Latest Developments 11.15 Novo Nordisk 11.15.1 Novo Nordisk Company Information 11.15.2 Novo Nordisk Innovative Medicine Product Offered 11.15.3 Novo Nordisk Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 Novo Nordisk Main Business Overview 11.15.5 Novo Nordisk Latest Developments 11.16 Allergan 11.16.1 Allergan Company Information 11.16.2 Allergan Innovative Medicine Product Offered 11.16.3 Allergan Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 Allergan Main Business Overview 11.16.5 Allergan Latest Developments 11.17 Takeda 11.17.1 Takeda Company Information 11.17.2 Takeda Innovative Medicine Product Offered 11.17.3 Takeda Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Takeda Main Business Overview 11.17.5 Takeda Latest Developments 11.18 Boehringer Ingelheim 11.18.1 Boehringer Ingelheim Company Information 11.18.2 Boehringer Ingelheim Innovative Medicine Product Offered 11.18.3 Boehringer Ingelheim Innovative Medicine Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 Boehringer Ingelheim Main Business Overview 11.18.5 Boehringer Ingelheim Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(medicine)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |